4//SEC Filing
WaferGen Bio-systems, Inc. 4
Accession 0001368993-17-000025
CIK 0001368993operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 2:28 PM ET
Size
10.3 KB
Accession
0001368993-17-000025
Insider Transaction Report
Form 4
Schueren Robert Alan
Director
Transactions
- Disposition to Issuer
Common Stock
2017-02-28$7.35/sh−8,368$61,481→ 0 total(indirect: See Footnote)
Footnotes (3)
- [F1]Includes 3,049 restricted stock units ("RSUs").
- [F2]Pursuant to the Agreement and Plan of Merger, dated May 12, 2016, by and among WaferGen Bio-systems, Inc., Takara Bio USA Holdings, Inc., Walrus Acquisition Corporation and Takara Bio USA, Inc., (i) each issued and outstanding RSU was automatically vested and converted into the right to receive $7.347126 in cash, without interest, and (ii) each issued and outstanding share of common stock was automatically cancelled and converted into the right to receive $7.347126 in cash, without interest.
- [F3]All shares were held by Montclaire Partners ("Montclaire") and all RSUs were held by the reporting person as nominee and for the benefit of Montclaire.
Issuer
WaferGen Bio-systems, Inc.
CIK 0001368993
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001368993
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 2:28 PM ET
- Size
- 10.3 KB